Castle Biosciences, Inc. (CSTL:NASDAQ) closed at $32.75 on November 16, 2026, down 3.08% on the day. The stock trades 26.0% below its 52-week high of $44.28 and 84.8% above its 52-week low of $17.72. Over the past year, it lost 3.5%. Castle Biosciences, Inc. is part of the Health Care sector (Medical Specialities).
In 252 trading sessions since November 14, 2025, CSTL closed higher on 132 days (52%). Its best day was August 19, 2026 (+11.33%) and its worst was May 7, 2026 (-22.26%). The stock moved 10% or more in a single session 3 times. It opened at least 5% above the previous day's high 1 time.
Castle Biosciences Inc is a United States-based company engaged in developing and commercializing diagnosis and prognostic tests for dermatologic cancers. Its non-invasive products utilize algorithms to provide an assessment of a patient's specific risk of metastasis or recurrence of their cancer. The product portfolio of the company includes Cutaneous Melanoma, DecisionDx-Melanoma, DecisionDx-CMSeq, and DecisionDx-PRAME among others.
Find more stocks like CSTL with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.